Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant

Pediatr Blood Cancer. 2020 Nov;67(11):e28528. doi: 10.1002/pbc.28528. Epub 2020 Aug 9.

Authors

Colette R Lauhan¹, Deborah Schiff¹, Nicholas Gloude¹

Affiliation

¹ Division of Pediatric Hematology Oncology, Department of Pediatrics, University of California San Diego, Rady Children's Hospital San Diego, San Diego, California.

PMID: 32776434
DOI: 10.1002/pbc.28528

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carboplatin / administration & dosage
Combined Modality Therapy
Etoposide / administration & dosage
Female
Hematopoietic Stem Cell Transplantation / methods*
Humans
Ifosfamide / administration & dosage
Liver Neoplasms / complications
Liver Neoplasms / pathology
Liver Neoplasms / therapy*
Lymphoma, T-Cell / complications
Lymphoma, T-Cell / pathology
Lymphoma, T-Cell / therapy*
Prognosis
Splenic Neoplasms / complications
Splenic Neoplasms / pathology
Splenic Neoplasms / therapy*
Turner Syndrome / complications
Turner Syndrome / pathology
Turner Syndrome / therapy*

Substances

Etoposide
Carboplatin
Ifosfamide